Lipid Management & Cardiovascular Disease Prevention Jerome Hines, MD West Suburban Cardiologists
Outline
Cardiovascular Disease Mortality
Prevalence of Coronary Disease United States
Cholesterol
Cholesterol Biosynthesis
One Small Step For Biochemists
One Giant Leap For Coronary Artery Disease Prevention
The Cholesterol Hypothesis & Epidemiology
Framingham Heart Study
Seven Countries Study
Multiple Risk Factor Intervention Trial (MRFIT)
Lipid Research Clinics Prevalence Study
Johns Hopkins Precursor Study
The Bogalusa Heart Study
Effects of Cholesterol Reduction
Clinical Events As Primary End Point
Secondary Prevention Trials
Coronary Drug Project
POSCH
Scandinavian Simvastatin Survival Study Group (4S)
Cholesterol and Recurrent Events Trial (CARE)
Primary Prevention Trials
The Oslo Study
WHO Trial
LRC Trial
Helsinki Heart Study
WOSCOP
West of Scotland
Cholesterol Reduction Saves Lives
NCEP CHD Risk Categories
Atorvastatin - Indications
Atorvastatin Dose-Response Relationship
CURVES Trial
CURVES Trial: LDL-C Reductions at Usual Starting Doses
CURVES Trial: LDL-C Reductions at Usual First Titrations
CURVES Trial: Conclusions
Treat to Target Trial
Treat to Target Trial: 12-Week Results
Summary
Email: jhines@cardiacmgmt.com
Home Page: http://www.westsubcardiology.com
Other information: Presented by Jerome Hines, MD of West Suburban Cardiologists in Chicago